(Q36969302)

17 August 2017

title

Raising standards while watching the bottom line: making a business case for infection control (English)

1 reference

Society for Healthcare Epidemiology of America

17 August 2017

author

7

object named as

Society for Healthcare Epidemiology of America

1 reference

17 August 2017

Eli N Perencevich

1

0 references

Sara E Cosgrove

6

object named as

Sara E Cosgrove

1 reference

17 August 2017

5

David N Fisman

1 reference

17 August 2017

Patricia W Stone

2

1 reference

17 August 2017

Sharon B Wright

3

1 reference

17 August 2017

Yehuda Carmeli

4

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Infection Control and Hospital Epidemiology

17 August 2017

published in

1 reference

17 August 2017

volume

28

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1121-1133

1 reference

The control of confounding by intermediate variables

17 August 2017

cites work

1 reference

APACHE II: a severity of disease classification system

21 January 2018

1 reference

Reference group choice and antibiotic resistance outcomes

21 January 2018

1 reference

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

21 January 2018

1 reference

Bias in published cost effectiveness studies: systematic review

21 January 2018

1 reference

Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery

21 January 2018

1 reference

Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units

21 January 2018

1 reference

Public reporting and pay for performance in hospital quality improvement

21 January 2018

1 reference

First year of mandatory reporting of healthcare-associated infections, Pennsylvania: an infection control-chart abstractor collaboration

21 January 2018

1 reference

A descriptive review of malpractice claims for health care-acquired infections in Philadelphia

21 January 2018

1 reference

Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a medical intensive care unit

21 January 2018

1 reference

Distribution of variable vs fixed costs of hospital care

21 January 2018

1 reference

Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients?

21 January 2018

1 reference

Of models and methods: our analytic armamentarium applied to methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Transmission dynamics and control of severe acute respiratory syndrome

21 January 2018

1 reference

The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care.

21 January 2018

1 reference

Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing

21 January 2018

1 reference

Evaluating treatment protocols to prevent antibiotic resistance

21 January 2018

1 reference

Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals

21 January 2018

1 reference

Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs

21 January 2018

1 reference

A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance.

21 January 2018

1 reference

Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey

21 January 2018

1 reference

Evaluation of outcome of intravenous catheter-related infections in critically ill patients.

21 January 2018

1 reference

Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.

21 January 2018

1 reference

Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.

21 January 2018

1 reference

Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus

21 January 2018

1 reference

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

21 January 2018

1 reference

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.

21 January 2018

1 reference

Impact of ventilator-associated pneumonia on resource utilization and patient outcome

21 January 2018

1 reference

Methods for the analysis of incidence rates in cluster randomized trials

21 January 2018

1 reference

Current and future challenges in the design and analysis of cluster randomization trials

21 January 2018

1 reference

Design and analysis issues in cluster-randomized trials of interventions against infectious diseases

21 January 2018

1 reference

The use and interpretation of quasi-experimental studies in infectious diseases.

21 January 2018

1 reference

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

Systematic review of economic analyses of health care-associated infections

21 January 2018

1 reference

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

The business case for quality: case studies and an analysis.

21 January 2018

1 reference

State-of-the-science--2004: time for a "No Excuses/No Tolerance" (NET) strategy

21 January 2018

1 reference

Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop

21 January 2018

1 reference

The distinction between cost and charges

21 January 2018

1 reference

A synthesis of cost-utility analysis literature in infectious disease

21 January 2018

1 reference

Infection control and cost control in the era of managed care

21 January 2018

1 reference

Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital

21 January 2018

1 reference

Infection control - a problem for patient safety

21 January 2018

1 reference

The impact of antimicrobial resistance on health and economic outcomes

21 January 2018

1 reference

From expert data collectors to interventionists: changing the focus for infection control professionals

21 January 2018

1 reference

Health and economic impact of surgical site infections diagnosed after hospital discharge.

21 January 2018

1 reference

Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections.

21 January 2018

1 reference

Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms

21 January 2018

1 reference

Preoperative drug dispensing as predictor of surgical site infection

21 January 2018

1 reference

A chronic disease score from automated pharmacy data

21 January 2018

1 reference

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

Antimicrobial resistance and patient outcomes: the hazards of adjustment

21 January 2018

1 reference

Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial

21 January 2018

1 reference

Results of a Comprehensive Infection Control Program for Reducing Surgical-Site Infections in Coronary Artery Bypass Surgery

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/521852

1 reference

17 August 2017

1 reference